CF Foundation | National Annual Meeting: CFTR Modulators in Younger Age Groups

Published on februari 8, 2021 by

During our first National Annual Meeting, Bruce Marshall, MD, our executive vice president and chief medical officer, shares our goal of ensuring highly effective CFTR modulators are expanded to younger age groups of the cystic fibrosis community.

Originally recorded January 28, 2021.


Add your comment

Your email address will not be published.